TTEC was founded in 2010 as a joint venture between the Wilmer Eye Institute and the Johns Hopkins University Department of Biomedical Engineering to establish a focus in research, education, and industrial development in the field of regenerative medicine.
Develop adaptive therapeutics, platform technologies, and fundamental knowledge for treating pathologies and regenerating damaged tissues and translate them to the clinic. Educate the next generation of scientists to be thought leaders in tissue engineering, regenerative medicine, and immunoengineering who will broadly impact society.
Translational Research: Our center provides a link from basic research to therapeutic development to clinical trials and start-up companies. We strategically connect students, research scientists and clinical faculty with the goal of facilitating funded, interdisciplinary research projects.
Thought Leadership: We aim to lead nationally and internationally in the development of innovative and adaptive therapeutics, platform technologies, and fundamental knowledge. The center is a nucleus for groundbreaking tissue engineering and immunoengineering research.
Education: We encourage our undergraduate, graduate, medical, and post-doctoral trainees to perform interdisciplinary research that integrates rigorous computational and experimental approaches. We provide a combination of hands-on research mentorship and interactive coursework. We provide resources that expand educational access to the lay public.
Community & Inclusion: We create a welcoming and inclusive environment for everyone that promotes collaboration, positivity, and collegiality among our trainees, faculty, and staff. We empower our early career leaders to promote a culture of engagement and belonging within our center. We develop the structure and resources to encourage scientific inquiry in the fields of tissue engineering and immunoengineering amongst the Baltimore education community.
